Table II.

Cumulative Percentage of Patients Achieving Efficacy Goals With Olmesartan Medoxomil + Hydrochlorothiazide (HCTZ) at Week 16*

Efficacy Goal	%of Patients
SeDBP
≥90 mm Hg	96.1
≥85 mm Hg	87.2
SeSBP
≥140 mm Hg	86.0
≥130 mm Hg	72.6
Responders**	96.1
SeDBP=seated diastolic blood pressure; SeSBP=seated systolic blood pressure; *based on the eligible patient population (n=179); **SeDBP <90 mm Hg or decreased by ≥10 mm Hg